Pure Bioscience Inc
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. Its technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. The comp… Read more
Pure Bioscience Inc (PURE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of January 2025: 0.127x
Based on the latest financial reports, Pure Bioscience Inc (PURE) has a cash flow conversion efficiency ratio of 0.127x as of January 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-544.00K) by net assets ($-4.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pure Bioscience Inc - Cash Flow Conversion Efficiency Trend (1996–2024)
This chart illustrates how Pure Bioscience Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Pure Bioscience Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pure Bioscience Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Brisbane Broncos Ltd
AU:BBL
|
0.099x |
|
CDT Environmental Technology Investment Holdings Limited ordinary shares
NASDAQ:CDTG
|
-0.045x |
|
PT Cipta Perdana Lancar Tbk
JK:PART
|
0.107x |
|
Chia Yi Steel Co Ltd
TWO:2067
|
0.005x |
|
NIPPON PROLOGIS REIT INC.
F:9NPA
|
N/A |
|
LEGEND POWER SYS INC.
F:XLE1
|
N/A |
|
Cauldron Energy Limited
PINK:CAULF
|
-0.606x |
|
Tarena International Inc
NASDAQ:TCTM
|
N/A |
Annual Cash Flow Conversion Efficiency for Pure Bioscience Inc (1996–2024)
The table below shows the annual cash flow conversion efficiency of Pure Bioscience Inc from 1996 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-07-31 | $-2.86 Million | $-2.53 Million | 0.884x | +107.33% |
| 2023-07-31 | $272.00K | $-3.28 Million | -12.051x | -1848.27% |
| 2022-07-31 | $3.91 Million | $-2.42 Million | -0.619x | -76.67% |
| 2021-07-31 | $3.33 Million | $-1.17 Million | -0.350x | -351.79% |
| 2020-07-31 | $4.81 Million | $669.00K | 0.139x | +105.53% |
| 2019-07-31 | $1.19 Million | $-2.99 Million | -2.513x | +17.19% |
| 2018-07-31 | $1.28 Million | $-3.89 Million | -3.034x | +14.20% |
| 2017-07-31 | $1.29 Million | $-4.56 Million | -3.536x | -255.91% |
| 2016-07-31 | $5.02 Million | $-4.99 Million | -0.994x | +60.95% |
| 2015-07-31 | $2.38 Million | $-6.06 Million | -2.544x | +99.32% |
| 2014-07-31 | $17.00K | $-6.33 Million | -372.118x | -9545.92% |
| 2013-07-31 | $-991.00K | $-3.90 Million | 3.939x | +157.67% |
| 2012-07-31 | $818.00K | $-5.59 Million | -6.831x | -369.44% |
| 2011-07-31 | $4.21 Million | $-6.12 Million | -1.455x | -42.13% |
| 2010-07-31 | $5.39 Million | $-5.52 Million | -1.024x | -22.42% |
| 2009-07-31 | $7.07 Million | $-5.91 Million | -0.836x | -88.81% |
| 2008-07-31 | $9.94 Million | $-4.40 Million | -0.443x | +27.73% |
| 2007-07-31 | $4.36 Million | $-2.67 Million | -0.613x | -90.01% |
| 2006-07-31 | $7.55 Million | $-2.44 Million | -0.323x | -434.72% |
| 2005-07-31 | $2.96 Million | $-178.60K | -0.060x | +89.90% |
| 2004-07-31 | $2.43 Million | $-1.45 Million | -0.597x | -103.99% |
| 2003-07-31 | $3.37 Million | $-987.46K | -0.293x | 0.00% |
| 2002-07-31 | $3.37 Million | $-987.46K | -0.293x | +8.59% |
| 2001-07-31 | $3.46 Million | $-1.11 Million | -0.320x | +5.34% |
| 2000-07-31 | $4.60 Million | $-1.56 Million | -0.338x | -63.58% |
| 1999-07-31 | $2.90 Million | $-600.00K | -0.207x | +78.28% |
| 1998-07-31 | $2.10 Million | $-2.00 Million | -0.952x | -156.41% |
| 1997-07-31 | $3.50 Million | $-1.30 Million | -0.371x | -112.38% |
| 1996-07-31 | $-100.00K | $-300.00K | 3.000x | -- |